%0 Journal Article
%T IDH1/2基因突变与急性髓系白血病的关系及作用的研究进展<br>Research Progress in the Relationship and Role of IDH1/2 Gene Mutation and Acute My-eloid Leukemia
%A 戚栋铭
%A 李丽
%J Advances in Clinical Medicine
%P 9202-9210
%@ 2161-8720
%D 2023
%I Hans Publishing
%R 10.12677/ACM.2023.1361289
%X 异柠檬酸脱氢酶(Isocitrate dehydrogenase, IDH)是三羧酸循环(Tricarboxylic acid cycle, TCA)中细胞呼吸的必需酶，在细胞代谢的过程中发挥重要作用。越来越多的证据表明IDH同血液系统恶性肿瘤的发生密切相关，研究发现IDH是急性髓系白血病(Acute myeloid leukemia, AML)的重要驱动基因，对AML的预后，疗效监测及靶向治疗具有重要的影响。本文将对IDH在AML方面的研究进展作一综述。<br />
Isocitrate dehydrogenase (IDH) is essential for cellular metabolism by functioning as an essential enzyme for cellular respiration in the tricarboxylic acid (TCA) cycle. The high correlation between IDH and the development of hematological malignancies has been confirmed by a mounting amount of data. As an important driven gene in acute myeloid leukaemia (AML), the study of IDH has im-portant implications for the prognosis, monitoring of efficacy and targeted therapy in AML. In this article, we mainly summary and review the progress of IDH research in AML.
%K 急性髓系白血病，IDH，抑制剂，预后<br>Acute Myeloid Leukemia
%K IDH
%K Inhibitor
%K Prognosis
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=66961